Rothwell Investment Advisors, LLC’s Transmedics TMDX Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.17K	Buy	+26	New	+$2.14K	﹤0.01%	1028

Other funds holding TMDX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Zevenbergen Capital Investments Edmonds, Washington $4.37B AUM 52.9% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return

Rothwell Investment Advisors, LLC's TMDX Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Transmedics (TMDX) in Q3 2026: 26 shares worth $2.17K. The stake represents ﹤0.01% of the portfolio and ranks #1028 among its holdings.

172 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

Rothwell Investment Advisors, LLC held 26 shares of Transmedics worth $2.17K as of Q3 2026.
Transmedics was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Transmedics made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #1028 holding.
172 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.